Omada Health Q1 revenue $78M (+42% YoY); members top 1M, net loss narrows to $3M

Omada Health, Inc.

2026-Q1 EPS reported -$0.05 revenue$78,048,000

Revenue $78M, up 42% YoY; total members 1.02M, up 51% YoY.
Net loss $3M vs $9M in Q1 2025; adjusted EBITDA positive $1M vs -$4M.
Joined Optum Rx Weight Engage; now relationships with all three top PBMs covering 80% of U.S. prescription claims.
Gross margin 62% (non-GAAP 64%), up from 58% (non-GAAP 60%) YoY.
Announced independent program administrator for Eli Lilly Employer Connect; GLP-1 Care Track data shows 1.8x weight loss.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Omada Health, Inc. reported first quarter ended March 31, 2026 results: revenue $78 million in the first quarter, net income Net loss of $3 million in the first quarter.

Period: first quarter ended March 31, 2026
Revenue: $78 million in the first quarter
Net income: Net loss of $3 million in the first quarter
Result: reported results

Exact text from the filing

million Total Members at the end of Q1, up 51% year over year, reinforcing Omada’s role as an integrated, multi-condition cardiometabolic platform operating at scale. • Revenue: $78 million in the first quarter, up 42% year over year. • Omada joined Optum Rx’s Weight Engage portfolio to help employers expand responsible, clinically supported access to GLP‐1 and

View on SEC.gov

Browse all earnings releases →

Omada Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-032063

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.